A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives

被引:0
作者
Abas Sezer
Mervisa Halilović-Alihodžić
Annissa Rachel Vanwieren
Adna Smajkan
Amina Karić
Husein Djedović
Jasmin Šutković
机构
[1] International University of Sarajevo,Genetics and Bioengineering
[2] Ludwig-Maximilians-Universität München,Fakultät Chemie und Pharmazie
来源
Journal of Genetic Engineering and Biotechnology | / 20卷
关键词
COVID-19; Drug repurposing; Herbal medicine; Remdesivir; Ivermectin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 564 条
[1]  
de Paulo Farias D(2020)COVID-19 outbreak: What should be done to avoid food shortages? Trends Food Sci Technol 102 291-741
[2]  
dos Santos Gomes MG(2021)Drug repurposing for COVID-19: Approaches, challenges and promising candidates Pharmacol Ther 228 107930-165
[3]  
Ng YL(2021)Drug repurposing for COVID-19 via knowledge graph completion J Biomed Inform 115 103696-18
[4]  
Salim CK(2021)A review on drug repurposing applicable to COVID-19 Brief Bioinform 22 726-759
[5]  
Chu JJH(2018)Drug repositioning: concept, classification, methodology, and importance in rare/orphans and neglected diseases J Appl Pharm Sci 8 157-307
[6]  
Zhang R(2020)Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 Cell Discov 6 1-58
[7]  
Hristovski D(2021)Extracellular vesicles as a next-generation drug delivery platform Nat Nanotechnol 16 748-1508
[8]  
Schutte D(2021)Repurposing drugs for the management of COVID-19 Expert Opin Ther Patents 31 295-71
[9]  
Kastrin A(2019)Drug repurposing: progress, challenges and recommendations Nat Rev Drug Discov 18 41-3298
[10]  
Fiszman M(2020)Drug repurposing approach to fight COVID-19 Pharmacol Rep 72 1479-41